Showing results (71-80 of 96) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trialsEmmanuel Mitry, Anthony L A Fields, Harry Bleiberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Expanded Low Allele Frequency <i>RAS</i> and <i>BRAF</i> V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 TrialJonathan M Loree, Anthony Dowers, Dongsheng Tu, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 2, 2015
Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranibSuzanne Richter, Jo-An Seah, Gregory R Pond, et al.The New England Journal of Medicine|November 16, 2007
Cetuximab for the treatment of colorectal cancerDerek J Jonker, Chris J O'Callaghan, Christos S Karapetis, et al.Journal of the National Cancer Institute|August 12, 2009
Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trialNicole Mittmann, Heather-Jane Au, Dongsheng Tu, et al.The New England Journal of Medicine|October 24, 2008
K-ras mutations and benefit from cetuximab in advanced colorectal cancerChristos S Karapetis, Shirin Khambata-Ford, Derek J Jonker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2024
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical TrialsJoao Paulo Solar Vasconcelos, Nan Chen, Emma Titmuss, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 TrialHeather-Jane Au, Christos S Karapetis, Chris J O'Callaghan, et al.International Journal of Radiation Oncology, Biology, Physics|September 8, 2014
Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancerKathy Han, Bernard J Cummings, Patricia Lindsay, et al.Cancer|May 31, 2013
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancerEdward J Kim, Edgar Ben-Josef, Joseph M Herman, et al.Pageof 10